Home » Newsletters » BioWorld

BioWorld

Jan. 25, 1994

View Archived Issues

BIOTECH SUMMIT DELIVERS IDEAS BUT NO AGENDA

INFLAZYME PARTNERSHIP FOR TB TEST

PHYTERA PRIVATE FINANCING RAISES $10.1M

APPOINTMENTS AND ADVANCEMENTS

RESEARCHERS DISCUSS SAFETY OF VIRAL VECTORS AT BIOEAST

GIBBONS PRAISES BIOTECH AT SUMMIT

SPARTA PHARMACEUTICALS FILES IPO TO RAISE $9.8M

GENPHARM GETS $3.1M FOR ANIMAL RESEARCH

HITACHI CHEMICAL CREATES GENE PROBE DESIGN BUSINESS

CORANGE MAKES INITIAL INVESTMENT IN CELLPRO

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026